Experimental HIV Vaccine Neutralizes 49% Of Variants In Animal Trials
An experimental HIV vaccine developed by the Karolinska Institute in Sweden successfully neutralized up to 49% of virus variants during animal testing. The study utilizes proteins to stimulate the immune system and generate more effective antibodies.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Universal 88.1 CDMX
“una vacuna experimental contra el VIH desarrollada por el Instituto Karolinska en Suecia logró neutralizar hasta el 49% de las variantes del virus en pruebas con animales.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade